Related Experiment Video
Updated: Jun 2, 2026
14:45
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
Activated immune cells in Parkinson's disease
Jun-Jun Cao1, Kang-Sheng Li, Yan-Qin Shen
1Animal Core, Shantou University Medical College, Shantou 515041, China.
Summary
Immune cells, including microglia and T lymphocytes, significantly impact Parkinson's disease (PD) progression. Understanding these interactions is crucial for developing new PD treatments.
Area of Science:
- Neuroimmunology
- Neurodegenerative Diseases
- Parkinson's Disease Pathogenesis
Background:
- Emerging evidence highlights the interplay between neurodegeneration and immune responses.
- Microglia activation and T-cell infiltration are observed in Parkinson's disease (PD) patients and models.
- The immune system's role in PD pathogenesis is an area of active research.
Purpose of the Study:
- To review the current understanding of microglial roles in PD progression.
- To discuss the plasticity of microglial responses in the context of PD.
- To examine the influence of peripheral T-cell subsets on PD and their potential mechanisms of action.
Main Methods:
- Literature review and synthesis of existing research on neuroinflammation in Parkinson's disease.
- Analysis of studies investigating microglia and T-cell interactions in PD.
- Discussion of immunological pathways implicated in PD pathogenesis.
Main Results:
- Microglia activation and peripheral T-cell infiltration are key features in PD.
- Microglial plasticity influences disease progression.
- Specific T-cell subsets may modulate PD pathogenesis through various pathways.
Conclusions:
- Innate and adaptive immune cells, particularly microglia and T cells, play a significant role in Parkinson's disease.
- Further research into immune cell interactions is vital for understanding PD pathogenesis.
- Targeting neuroimmune pathways may offer therapeutic strategies for Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.